Moderna reports fiscal Q3 2025 results: revenue $1.02B, down 45% from a year earlier

Moderna filed a Form 8-K with the SEC on Nov 6, 2025, 7:03 AM ET, reporting an event dated Nov 6, 2025. It covers Item 2.02 (Results of Operations and Financial Condition); Item 9.01 (Financial Statements and Exhibits). The results cover fiscal Q3 2025 (quarter ended Sep 30, 2025); figures below are from the company's XBRL financial data filed with the SEC.

• Revenue: $1.02B (−45.4% from $1.86B a year earlier)
• Operating income: −$260.0M (vs −$70.0M a year earlier)
• Net income: −$200.0M (vs $13.0M a year earlier)
• Diluted EPS: $-0.51 (vs $0.03 a year earlier)
• Form 8-K accepted by EDGAR Nov 6, 2025, 7:03 AM ET
• Accession number 0001682852-25-000073

SEC filing 8-K · accession 0001682852-25-000073 · sec.gov ↗